Glaukos Corp (GKOS)
$237.60 -2.01% Close Oct 30, 2026 Live
Glaukos stock today
Glaukos closed at $237.60 on October 30, 2026, down 2.01% on the day. Over the past year it returned +170.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $14.0 billion.
$100.00$150.00$200.00$250.00
NovJan 2026MarMayJulSep
| Period | GKOS | S&P 500 (SPY) |
|---|---|---|
| 1 month | +44.7% | -0.9% |
| 3 months | +41.0% | +2.1% |
| Year to date | +110.4% | +11.7% |
| 1 year | +170.6% | +12.4% |
| 3 years | +255.6% | +88.5% |
| 5 years | +419.8% | +76.0% |
Key statistics
- Market value
- $14.0B
- Forward P/E
- 223.7
- Price / sales
- 20.3
- 52-week range
- $81.79 to $242.48
About Glaukos
Glaukos Corporation develops and sells minimally invasive glaucoma surgery devices and treatments.
Sector: Health Care
More on Glaukos
- Financials: revenue, earnings and segmentsRevenue +32% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $7,277 today
No forecast, no recommendation. This page describes Glaukos Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.